PRF Technologies Ltd. (PRFX) Fair Value 2026

PRFX · Drug Manufacturers - Specialty & Generic ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.7 /10

32 fundamental signals · 1 models active

Value Trap Risk

DANGER (68/100)

Quick Summary — As of 2026-08-28, PRF Technologies Ltd. (PRFX) trades at $0.96. QOC: 4.7/10. Value Trap Risk: 68/100 (DANGER). 1/13 models active.

Key Facts

Ticker
PRFX
Price
$0.96
Quality Score
4.7/10
Value Trap Risk
68/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Value Trap score of 68 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give PRFX?

1 Intrinsic Value Models vs. Current Price ($0.96)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.57 -40.6%

All Models Active

All 1 models are displayed above.

What Is PRF Technologies Ltd. (PRFX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, PRF Technologies Ltd.'s intrinsic value is estimated at $0.57. Trading at its current price of $0.96, the valuation engine raises significant caution: 1 of 1 models flag downside risk, projecting a median implied return of -40.6%.

What Do the Models Say About PRFX?

1 of 13 models are currently active for PRFX. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does PRFX Rank in Drug Manufacturers - Specialty & Generic?

Among 112 Drug Manufacturers - Specialty & Generic stocks, PRFX ranks #87 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.

See all Most Undervalued Drug Manufacturers - Specialty & Generic Stocks →

PRF Technologies Ltd.'s positioning within the Drug Manufacturers - Specialty & Generic segment means that patent cliff exposure plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.

Is PRFX a Value Trap?

CirclFi's Value Trap algorithm assigns PRFX a score of 68/100 (DANGER). This is a high-risk signal. Deteriorating fundamentals suggest the discount may be justified. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for PRF Technologies Ltd.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, PRF Technologies Ltd. earns a quality score of 4.7/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. However, our Value Trap algorithm flags elevated risk — suggesting that apparent cheapness may mask deteriorating fundamentals.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PRFX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PRFX's 1 active models, average confidence is 63%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy PRF Technologies Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Drug Manufacturers - Specialty & Generic Stocks Should You Also Analyze?

11 related Drug Manufacturers - Specialty & Generic stocks with 13-model coverage

PLNHPlanet 13 Holdings Inc.QOC 4.7PNXPPineapple Express Cannabis CompanyQOC 4.7GELSGelteq LimitedQOC 4.7CPMDCannaPharmaRX, Inc.QOC 4.6BTAIBioXcel Therapeutics, Inc.QOC 4.7RAPHRaphael Pharmaceutical Inc.QOC 4.6ZTSZoetis Inc.QOC 9.3LQDALiquidia CorporationQOC 7.0AQSTAquestive Therapeutics, Inc.QOC 6.0UTHRUnited Therapeutics CorporationQOC 9.6AMPHAmphastar Pharmaceuticals, Inc.QOC 9.4

Read investment analysis: PLNH · PNXP · GELS · CPMD · BTAI · RAPH · ZTS · LQDA · AQST · UTHR · AMPH

Which Other Stocks Have a Similar Quality Score to PRFX?

7 companies across all industries closest to PRFX’s Quality of Company score of 4.7/10.

RZLTRezolute, Inc.QOC 4.7GHSTGHST World Inc.QOC 4.7CBIOCrescent Biopharma, Inc.QOC 4.7RBNERobin Energy Ltd.QOC 4.7AIXNAiXin Life International, Inc.QOC 4.7HSTCHST Global, Inc.QOC 4.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: RZLT · GHST · CBIO · RBNE · AIXN · HSTC · NVDA

Where Does PRFX Sit in CirclFi's Drug Manufacturers - Specialty & Generic Rankings?

PRFX is ranked against every other Drug Manufacturers - Specialty & Generic stock CirclFi covers in each of these screens.

See all Drug Manufacturers - Specialty & Generic stocks ranked →

What Else Do Investors Ask About PRF Technologies Ltd.’s Valuation?

What is PRF Technologies Ltd.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for PRF Technologies Ltd. (PRFX). The Quality of Company score is 4.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PRFX overvalued or undervalued right now?

At $0.96, 0 of 1 active models suggest PRFX may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits PRF Technologies Ltd.'s business model in Drug Manufacturers - Specialty & Generic.

What does a Quality of Company score of 4.7 mean for PRFX?

PRF Technologies Ltd.'s QOC of 4.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on PRFX?

CirclFi analyzes PRFX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is PRFX a value trap in 2026?

PRF Technologies Ltd.'s Value Trap score is 68/100 (DANGER). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns PRF Technologies Ltd. (PRFX) a Quality of Company score of 4.7/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/PRFX/ · Methodology
Primary sources for this PRFX valuation
  • Financial statements: PRF Technologies Ltd. 10-K and 10-Q filings on SEC EDGAR (CIK 0001801834) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PRFX as of ; valuations recomputed .